Actuate Therapeutics, Inc. (NASDAQ: ACTU) is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers. Actuate’s lead investigational drug product, elraglusib (a novel GSK-3β inhibitor), targets molecular pathways in canc...
Use this information to figure out if this company is an ideal customer for you.
847.986.4190
1401 Foch Street
Fort Worth, 76107
51 - 200 Employees
$5M - $20M
linkedin.com/company/actuate-therapeutics-inc.
Actuate Therapeutics Inc.'s CEO is Dan Schmitt
Actuate Therapeutics Inc.'s HQ is located at 1401 Foch Street, Fort Worth
Actuate Therapeutics Inc.'s phone number is 847.986.4190
Actuate Therapeutics Inc.'s official website is actuatetherapeutics.com
Actuate Therapeutics Inc.'s revenue is $5M - $20M
Actuate Therapeutics Inc. has 51 - 200 employees
Actuate Therapeutics Inc. is in the industry of: Pharmaceuticals
